Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThird Poi. $ Regulatory News (TPOU)

  • This share is currently suspended. It was suspended at a price of 20.30
  • There is currently no data for TPOU

Kepler Trust Intelligence: New Research

1 Oct 2020 08:00

RNS Number : 6931A
Third Point Investors Limited
01 October 2020
 

Third Point Investors: New research

01/10/2020

TPOU's portfolio has been pivoted year to date, and with renewed focus from board and manager, the discount of 23% looks anomalous…

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

 

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 9/10 Savile Row, London W1S 3PF with registered number OC334771.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Private Policy.
 
END
 
 
NRAEAENEDFPEEAA
Date   Source Headline
4th Apr 20223:52 pmPRNNet Asset Value(s)
4th Apr 20227:00 amPRNTransaction in Own Shares
1st Apr 20224:34 pmPRNTotal Voting Rights
1st Apr 20222:37 pmPRNNet Asset Value(s)
30th Mar 20225:35 pmPRNTransaction in Own Shares
29th Mar 20225:26 pmPRNTransaction in Own Shares
29th Mar 202210:02 amPRNTransaction in Own Shares
25th Mar 20224:25 pmPRNNet Asset Value(s)
25th Mar 20223:51 pmPRNNet Asset Value(s)
25th Mar 20229:17 amPRNTransaction in Own Shares
24th Mar 20229:33 amPRNTransaction in Own Shares
21st Mar 20225:40 pmPRNTransaction in Own Shares
21st Mar 20227:00 amPRNResults of 2022 Exchange Facility
18th Mar 20221:24 pmPRNNet Asset Value(s)
18th Mar 20229:19 amPRNTransaction in Own Shares
16th Mar 20225:52 pmPRNTransaction in Own Shares
15th Mar 20225:36 pmPRNTransaction in Own Shares
15th Mar 20229:14 amPRNTransaction in Own Shares
11th Mar 20225:54 pmPRNTransaction in Own Shares
11th Mar 20223:38 pmPRNNet Asset Value(s)
8th Mar 20225:00 pmPRNTransaction in Own Shares
7th Mar 20225:39 pmPRNTransaction in Own Shares
4th Mar 20225:41 pmPRNTransaction in Own Shares
4th Mar 20224:39 pmPRNNet Asset Value(s)
4th Mar 20227:00 amPRNMonthly Update: February 2022 NAV Performance
3rd Mar 20225:25 pmPRNTransaction in Own Shares
2nd Mar 20225:36 pmPRNTransaction in Own Shares
2nd Mar 20225:04 pmPRNNet Asset Value(s)
1st Mar 20225:43 pmPRNTotal Voting Rights
28th Feb 20225:29 pmPRNTransaction in Own Shares
25th Feb 20225:26 pmPRNNet Asset Value(s)
25th Feb 20225:18 pmPRNNet Asset Value(s)
23rd Feb 20225:19 pmPRNTransaction in Own Shares
22nd Feb 20225:10 pmPRNTransaction in Own Shares
21st Feb 20225:21 pmPRNTransaction in Own Shares
18th Feb 20225:34 pmPRNTransaction in Own Shares
18th Feb 20223:27 pmPRNNet Asset Value(s)
18th Feb 202212:35 pmPRNBoard and Shareholder Update
17th Feb 20225:13 pmPRNTransaction in Own Shares
16th Feb 20225:29 pmPRNTransaction in Own Shares
15th Feb 20225:39 pmPRNTransaction in Own Shares
14th Feb 20225:33 pmPRNTransaction in Own Shares
11th Feb 20224:27 pmPRNNet Asset Value(s)
8th Feb 20225:01 pmPRNTransaction in Own Shares
8th Feb 20223:45 pmPRNShareholder Communication
7th Feb 20225:09 pmPRNTransaction in Own Shares
4th Feb 20225:41 pmPRNTransaction in Own Shares
4th Feb 20224:15 pmPRNNet Asset Value(s)
4th Feb 20227:00 amPRNMonthly Update: January 2022 NAV Performance
2nd Feb 20224:34 pmPRNNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.